■ IgD モノクローナル抗体(品番:65175-1-Ig)
図1. IgD抗体とCD19抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD19 (APC-65110, Clone: HIB19), 1 ug Anti-Human IgD (65175-1-Ig, Clone: IA6-2) and CoraLite®488-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:500. Cells were not fixed.図2. アイソタイプコントロール抗体とCD19抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD19 (APC-65110, Clone: HIB19), 1 ug Mouse IgG2a isotype control and CoraLite®488-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:500. Cells were not fixed.
■ IgD モノクローナル抗体(品番:PE-65175)
図1. IgD抗体とCD19抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD19 (APC-65110, Clone:HIB19) and 10.00 ul/test PE Anti-Human IgD (PE-65175, Clone:IA6-2). Sample were not fixed.図2. アイソタイプコントロール抗体とCD19抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD19 (APC-65110, Clone:HIB19) and PE mouse IgG2a isotype control antibody. Sample were not fixed.
■ IgD モノクローナル抗体(品番:APC-65175)
図1. IgD抗体とCD19抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with PE Anti-Human CD19 (PE-65110, Clone:HIB19) and 10.00 ul/test APC Anti-Human IgD (APC-65175, Clone:IA6-2). Sample were not fixed.図2. アイソタイプコントロール抗体とCD19抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with PE Anti-Human CD19 (PE-65110, Clone:HIB19) and APC mouse IgG2a isotype control antibody. Sample were not fixed.